A Pharmacokinetic Approach to Preterm Labor Inhibition

References

• Creasy R K. Preterm labor and delivery. “Maternal-Fetal Medicine, Principles and Practice.”, R K Creasy, R Resnik. W.B. Saunders, Philadelphia 1989; 481
   Google Scholar
• Creasy R D, Gummer B A, Liggins G C. A system for predicting spontaneous preterm birth. Obstet Gynecol 1980; 55: 692
   PubMed Web of Science ®Google Scholar
• Katz M, Gill P J, Newman R B. Detection of preterm labor by ambulatory monitoring of uterine activity: a preliminary report. Obstet Gynecol 1986; 68: 733
   Google Scholar
• Caritis S N, Toig G, Heddinger L, Ashmead G. A double-blind study comparing ritodrine and terbutaline in the treatment of preterm labor. Am J Obstet Gynecol 1984; 150: 7–14
   PubMed Web of Science ®Google Scholar
• King J F, Grant A, Keirse M JN, Chalmers I. Beta-mimetics in preterm labor: an overview of the randomized clinical trials. Br J Obstet Gynecol 1988; 95: 211–222
   PubMedGoogle Scholar
• Huszar G B, Walsh M P. Relationship between myometrial and cervical functions in pregnancy and labor. Sem Perinatol 1991; 15: 97–117
   Google Scholar
• Soloff M S, Sweet P. Oxytocin inhibition of (calcium-magnesium)-ATPase activity in rat myometrial plasma membranes. J Biol Chemistry 1982; 257: 10687–10693
   Google Scholar
• Triggle D J, Janis R A. Calcium channel ligands. Annu Rev Pharmacol Toxicol 1987; 27: 347–369
   Google Scholar
• Rivera J, Lopez-Bernal A, Varney M, et al. Inositol 1,4,5-trisphosphate and oxytocin binding in human myometrium. Endocrinology 1990; 127: 155–162
   Google Scholar
• Garfield R E, Kannan M S, Daniel E E. Gap junction formation in myometrium: control by estrogens, progesterone, and prostaglandins. Am J Physiol 1980; 238: C81
   PubMed Web of Science ®Google Scholar
• Caritis S N, Hirsch R P, Zeleznik A J. Adrenergic stimulation of placental progesterone production. J Clin Endocrinol Metab 1983; 56: 969–972
   PubMedGoogle Scholar
• Caritis S N, Darby M J, Chan L. Pharmacologic treatment of preterm labor. Clin Obstet Gynecol 1988; 31: 635–651
   Google Scholar
• Boue J, Boue A, Lazar P. Retrospective and prospective epidemiological studies of 1500 karyotyped spontaneous abortions. Br J Obstet Gynecol 1975; 82: 366
   Google Scholar
• Lands A M, Arnold A, McAuliff J P, et al. Differentiation of receptor systems activated by sympathomimetic amines. Nature (London) 1967; 214: 597–598
   PubMed Web of Science ®Google Scholar
• Besinger R E, Niebyl J R. The safety and efficacy of tocolytic agents for the treatment of preterm labor. Obstet Gynecol Survey 1990; 45: 415–440
   PubMedGoogle Scholar
• Caritis S N. Treatment of preterm labor: A review of therapeutic options. Drugs 1983; 26: 243–261
   PubMed Web of Science ®Google Scholar
• Harden T K. Agonist-induced desensitization of the beta-adrenergic receptor-linked adenylate cyclase. Pharmacol Rev 1983; 35: 5–32
   PubMed Web of Science ®Google Scholar
• Casper R F, Lye S J. Beta-adrenergic receptor agonist infusion increases plasma prostaglandin F levels in pregnant sheep. Am J Obstet Gynecol 1987; 157: 998
   Google Scholar
• Benedetti T J. Maternal complications of parenteral beta-sympathomimetic therapy for preterm labor. Am J Obstet Gynecol 1983; 145: 1–6
   PubMed Web of Science ®Google Scholar
• Caritis S N, Lin L S, Toig G, Wong L K. Pharmacodynamics of ritodrine in pregnant women during preterm labor. Am J Obstet Gynecol 1983; 147: 752–759
   PubMed Web of Science ®Google Scholar
• Roberts J M. Current understanding of pharmacologic mechanisms in the prevention of preterm birth. Clin Obstet Gynecol 1981; 27: 592–605
   Google Scholar
• Hendricks S K, Keroes J, Katz M. Electrocardiographic changes associated with ritodrine-induced maternal tachycardia and hypokalemia. Am J Obstet Gynecol 1986; 154: 921–923
   Google Scholar
• Caritis S N, Venkataraman R, Darby M J, et al. Pharmacokinetics of ritodrine administered intravenously: recommendations for changes in the current regimen. Am J Obstet Gynecol 1990; 162: 429–437
   PubMed Web of Science ®Google Scholar
• Ingemarrson I, Bengtsson B. A five-year experience with terbutaline for preterm labor: Low rate of severe side effects. Obstet Gynecol 1985; 66: 176–180
   Google Scholar
• Katz M, Robertson P, Creasy R K. Cardiovascular complications associated with terbutaline treatment for preterm labor. Am J Obstet Gynecol 1981; 139: 605–608
   PubMed Web of Science ®Google Scholar
• Hadders-Algra M, Touwen B CL, Huisjes J H. Long-term follow-up of children prenatally exposed to ritodrine. Br J Obstet Gynecol 1986; 93: 156
   PubMedGoogle Scholar
• Caritis S N, Venkataraman R, Cotroneo M, Chiao J P. Pharmacokinetics of orally-administered ritodrine. Am J Obstet Gynecol 1989; 161: 32–35
   PubMed Web of Science ®Google Scholar
• Caritis S N, Venkataraman R, Cotroneo M, Smith M, et al. Pharmacokinetics and pharmacodynamics of ritodrine after intramuscular administration to pregnant women. Am J Obstet Gynecol 1990; 162: 1215–1219
   Google Scholar
• Berg G, Lindberg C, Ryden G. Terbutaline in the treatment of preterm labor. Eur J Respir Dis 1984; 65: 219
   Google Scholar
• Lyrenas S, et al. Pharmacokinetics of terbutaline during pregnancy. Eur J Clin Pharmacol 1986; 29: 619
   Google Scholar
• Ingemarrson I, Westgren M, Lindberg C, et al. Single injection of terbutaline in term labor: Placental transfer and effects on maternal and fetal carbohydrate metabolism. Am J Obstet Gynecol 1981; 139: 697–701
   Google Scholar
• Ingermarrson I. Effect of terbutaline on preterm labor: A double-blind, placebo-controlled study. Am J Obstet Gynecol 1976; 125: 520–524
   Google Scholar
• Stubblefield P G, Heyl P S. Treatment of premature labor with subcutaneous terbutaline. Obstet Gynecol 1982; 59: 457–462
   Google Scholar
• Lam F, et al. Use of the subcutaneous terbutaline pump for long-term tocolysis. Obstet Gynecol 1988; 72: 810–813
   Google Scholar
• Caritis S N, Chiao J P, Kridgen P. Comparison of pulsatile and continuous ritodrine administration: Effect on uterine contractility and beta-adrenergic receptor cascade. Am J Obstet Gynecol 1991; 164: 1005–1012
   Google Scholar
• Gonik B, Benedetti T J, Creasy R K, Lee A FS. Intramuscular versus intravenous ritodrine hydrochloride for preterm labor management. Am J Obstet Gynecol 1988; 159: 323–328
   PubMed Web of Science ®Google Scholar
• Korenbrot C C, Aalto L H, Laros R K, Jr. The cost-effectiveness of stopping preterm labor with beta-adrenergic treatment. N Engl J Med 1984; 310: 691–696
   Google Scholar
• Petrie R H. Tocolysis using magnesium sulfate. Sem Perinatol 1981; 5: 266–273
   PubMed Web of Science ®Google Scholar
• Elliott J P. Magnesium sulfate as a tocolytic agent. Am J Obstet Gynecol 1983; 147: 277–284
   Google Scholar
• Elliott J P. Magnesium sulfate as a tocolytic agent. Contemp OB/GYN June, 1985; 49–61
   Google Scholar
• Wacker W EC, Parisi V. Magnesium metabolism. N Engl J Med 1968; 278: 658
   PubMed Web of Science ®Google Scholar
• Beall M H, Edgar B W, Paul R H, Smith-Wallace T. A comparison of ritodrine, terbutaline and magnesium sulfate for the suppression of preterm labor. Am J Obstet Gynecol 1985; 153: 854–859
   Google Scholar
• Cruikshank D P, Pitkin R M, Reynolds W A, et al. Effects of magnesium sulfate on perinatal calcium metabolism I: Maternal and fetal responses. Am J Obstet Gynecol 1979; 134: 243–249
   PubMed Web of Science ®Google Scholar
• Thiagarajah S, Harbert G, Bourgeois F J. Magnesium sulfate and titodrine hydrochloride: Systemic and uterine hemodynamic effects. Am J Obstet Gynecol 1985; 153: 666–674
   PubMed Web of Science ®Google Scholar
• Lipsitz P J. Clinical and biochemical effects of excess magnesium in the newborn. Pediatrics 1971; 47: 501–509
   PubMed Web of Science ®Google Scholar
• Stone S R, Pritchard J A. Effect of maternally-administered magnesium sulfate on the neonate. Obstet Gynecol 1970; 35: 574–577
   PubMed Web of Science ®Google Scholar
• Chesley L C. Parenteral magnesium sulfate and the distribution, plasma levels, and excretion of magnesium. Am J Obstet Gynecol 1979; 133: 1–7
   PubMedGoogle Scholar
• Martin R W, Gaddy D K, Martin J N, et al. Tocolysis with oral magnesium. Am J Obstet Gynecol 1987; 156: 433–434
   Google Scholar
• Hall D G, McGaughey H S, Corey E L, Thornton W N. The effects of magnesium therapy on the duration of labor. Am J Obstet Gynecol 1959; 78: 27–32
   PubMed Web of Science ®Google Scholar
• Harbert G M, Jr., Cornell G W, Thornton W N. Effect of toxemia therapy on uterine dynamics. Am J Obstet Gynecol 1969; 105: 94–104
   Google Scholar
• Cotton D B, Strassner H T, Hill L M, et al. Comparison of magnesium sulfate, terbutaline, and a placebo for inhibition of preterm labor. J Reprod Med 1984; 29: 92–97
   PubMed Web of Science ®Google Scholar
• Steer C M, Petrie R H. A comparison of magnesium sulfate and alcohol for the prevention of premature labor. Am J Obstet Gynecol 1977; 129: 1–4
   PubMed Web of Science ®Google Scholar
• Hollander D I, Nagey D A, Pupkin M J. Magnesium sulfate and ritodrine hydrochloride: A randomized comparison. Am J Obstet Gynecol 1987; 156: 631–637
   Google Scholar
• Miller J M, Keane M WD, Horger I EO, II. Comparison of magnesium sulfate and terbutaline for the arrest of premature labor: A preliminary report. J Reprod Med 1982; 27: 348–351
   Google Scholar
• Wilkins I A, Lynch L, Mehalek K E, et al. Efficacy and side effects of magnesium sulfate and ritodrine as tocolytic agents. Am J Obstet Gynecol 1988; 159: 685–689
   PubMed Web of Science ®Google Scholar
• Martin R W, Martin J N, Pryor J A, et al. Comparison of oral ritodrine and magnesium gluconate for ambulatory tocolysis. Am J Obstet Gynecol 1988; 158: 1440–1445
   Google Scholar
• Sellers S M, Mitchell M D, Bobby J G, et al. A comparison of plasma prostaglandin levels in term and preterm labour. Br J Obstet Gynecol 1981; 88: 362–366
   Google Scholar
• Keirse M JNC, Mitchell M D, Turnbull A C. Changes in prostaglandin F and 13, 14-dihydro-15-keto-prostaglandin F concentrations in amniotic fluid at the onset of and during labour. Br J Obstet Gynecol 1988; 84: 743–746
   Google Scholar
• Zuckerman H, Reiss U, Atad J, et al. The effect of indomethacin on plasma levels of prostaglandin F2 alpha in women in labour. Br J Obstet Gynecol 1977; 84: 339–343
   Google Scholar
• Novy M J. Effects of indomethacin on labor, fetal oxygenation, and fetal development in rhesus monkeys. Adv Prostaglandin Thromboxane Res 1978; 4: 285–300
   Google Scholar
• Helleberg L. Clinical pharmacokinetics of indomethacin. Clin Pharmacokinet 1981; 6: 245–258
   PubMed Web of Science ®Google Scholar
• Alvan G, Orme M, Bertilsson L, Ekstrand R, Palmer L. Pharmacokinetics of indomethacin. Clin Pharmacol Ther 1975; 18: 369–373
   Google Scholar
• Moise K J, Ou C N, Kirshon B, et al. Placental transfer of indomethacin in human pregnancy. Am J Obstet Gynecol 1990; 162: 549–554
   PubMed Web of Science ®Google Scholar
• Niebyl J R, Blake D A, White R D, et al. The inhibition of premature labor with indomethacin. Am J Obstet Gynecol 1980; 136: 1014–1019
   PubMed Web of Science ®Google Scholar
• Evans M A, Bhat R, Vidyasager D, et al. Gestational age and indomethacin elimination in the neonate. Clin Pharmacol Ther 1979; 26: 746–751
   Google Scholar
• Morse K J, Huhta J C, Sharif D S, et al. Indomethacin in the treatment of premature labor: Effects on the fetal ductus arteriosus. N Engl J Med 1988; 318: 327–331
   Google Scholar
• Cabrol D, Landesman R, Muller J, et al. Treatment of polyhydramnios with prostaglandin synthetase inhibitor (indomethacin). Am J Obstet Gynecol 1987; 157: 422–426
   Google Scholar
• Wurtzel D. Prenatal administration of indomethacin as a tocolytic agent: Effect on neonatal renal function. Obstet Gynecol 1990; 76: 689–692
   Google Scholar
• Heijden A J, Provoost A P, Nauta J, et al. Renal functional impairment in preterm neonates related to intrauterine indomethacin exposure. Pediatr Res 1988; 24: 644–648
   Google Scholar
• Zuckerman H, Shalev E, Gilad G, Katzuni E. Further study of the inhibition of premature labor by indomethacin: Part I. J Perinat Med 1984; 12: 19–23
   Google Scholar
• Dudley D K, Hardie M J. Fetal and neonatal effects of indomethacin used as a tocolytic agent. Am J Obstet Gynecol 1985; 151: 181–184
   PubMed Web of Science ®Google Scholar
• Niebyl J R, Witter F R. Neonatal outcome after indomethacin treatment for preterm labor. Am J Obstet Gynecol 1986; 155: 747–749
   PubMed Web of Science ®Google Scholar
• Zuckerman H, Shalev E, Gilad G, Katzuni E. Further study of the inhibition of premature labor by indomethacin: Part II. double-blind study. J Perinat Med 1984; 12: 25–29
   PubMed Web of Science ®Google Scholar
• Morales W J, Smith S G, Angel J L, et al. Efficacy and safety of indomethacin versus ritodrine in the management of preterm labor: A randomized study. Obstet Gynecol 1989; 74: 567–572
   PubMed Web of Science ®Google Scholar
• Raemisch K D, Sommer J. Pharmacokinetics and metabolism of nifedipine. Hypertension 1983; 5(Suppl. II)II-18–II-24
   Google Scholar
• McAllister R G. Kinetics and dynamics of nifedipine after oral and sublingual doses. Am J Med 1986; 81(Suppl 6A)2–5
   Google Scholar
• Ferguson J G, Schultz T, Pershe R, et al. Nifedipine pharmacokinetics during preterm labor tocolysis. Am J Obstet Gynecol 1989; 161: 1485–1490
   PubMed Web of Science ®Google Scholar
• Sorkin E M, Clissold S P, Brogden R N. Nifedipine: A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in ischemic heart disease, hypotension, and related cardiovascular disorders. Drugs 1985; 30: 182–274
   PubMed Web of Science ®Google Scholar
• Harake B, Gilbert R D, Ashwal S, Power G G. Nifedipine: Effects on fetal and maternal hemodynamics in pregnant sheep. Am J Obstet Gynecol 1989; 157: 1003–1008
   Google Scholar
• Veille J C, Bissonnette J M, Hohimer A R. The effect of a calcium channel blocker (nifedipine) in uterine blood flow in the pregnant goat. Am J Obstet Gynecol 1986; 154: 1160–1163
   PubMedGoogle Scholar
• Ferguson J E, Dyson D C, Holbrook R H, et al. Cardiovascular and metabolic effects associated with nifedipine and ritodrine tocolysis. Am J Obstet Gynecol 1989; 161: 788–795
   PubMed Web of Science ®Google Scholar
• Golichowski A M, Hathaway D R, Fineberg N, Peleg D. Tocolytic and hemodynamic effects of nifedipine in the ewe. Am J Obstet Gynecol 1985; 151: 1134–1140
   Google Scholar
• Andersson K E, Ingemarsson I, Ulmsten U, Wingerup L. Inhibition of prostaglandin-induced uterine activity by nifedipine. Br J Obstet Gynecol 1979; 86: 175–179
   Google Scholar
• Forman A, Gandrup P, Andersson K E, Ulmsten U. Effects of nifedipine on oxytocin-and prostaglandin F2 alpha-induced activity in the postpartum uterus. Am J Obstet Gynecol 1982; 144: 665–670
   Google Scholar
• Ulmsten U, Andersson K E, Forman A. Relaxing effects of nifedipine on the nonpregnant uterus in vitro and in vivo. Obstet Gynecol 1978; 52: 436–441
   Google Scholar
• Ferguson J E, Dyson D C, Schultz T, Stevenson D K. A comparison of tocolysis with nifedipine or ritodrine: Analysis of efficacy and maternal, fetal, and neonatal outcome. Am J Obstet Gynecol 1990; 163: 105–111
   PubMed Web of Science ®Google Scholar
• Read M D, Wellby D E. The use of a calcium antagonist (nifedipine) to suppress preterm labour. Br J Obstet Gynecol 1986; 93: 933–937
   PubMedGoogle Scholar
• Spearing G. Alcohol, indomethacin, and salbutamol. Obstet Gynecol 1979; 53: 171
   Google Scholar
• Ferguson J E, Hensleigh P A, Kredenster D. Adjunctive use of magnesium sulfate with ritodrine for preterm labor tocolysis. Am J Obstet Gynecol 1984; 148: 166–171
   Google Scholar
• Hatjis C G, Swain M, Nelson L H, et al. Efficacy of combined administration of magnesium sulfate and ritodrine in the treatment of preterm labor. Obstet Gynecol 1987; 69: 317–322
   Google Scholar
• Katz Z, Lancet M, Yemini M, et al. Treatment of preterm labor contractions with combined ritodrine and indomethacine. Int J Obstet Gynecol 1983; 21: 337–342
   PubMed Web of Science ®Google Scholar
• Caritis S N, et al. Am J Obstet Gynecol 1979; 133: 557–578
   PubMed Web of Science ®Google Scholar